论文部分内容阅读
现己认识伪膜性结肠炎(PMC)是抗生素治疗后改变肠道菌群所致的一种严重的并发症。药物治疗PMC的目的在于减少结肠内难辨梭状芽胞杆菌(Cl.difficile)毒素量及促进肠道菌群正常化。本文报道甲硝唑(又名灭滴灵)治疗30例PMC的疗效。
It is now recognized that pseudomembranous colitis (PMC) is a serious complication caused by altered gut microbiota after antibiotic treatment. The purpose of the drug treatment of PMC is to reduce the amount of Cl.difficile toxins in the colon and to promote the normalization of intestinal flora. This article reports the efficacy of metronidazole (also known as metronidazole) in the treatment of 30 cases of PMC.